{"rows":[{"id":3724,"title":"Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.","authors":"Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S","journal":"Pharmacology & therapeutics","publication_date":"2024-06-01","publication_year":2024,"doi":"10.1016/j.pharmthera.2024.108641","pubmed_id":"38583670","openalex_id":"https://openalex.org/W4394009974","source_url":"https://pubmed.ncbi.nlm.nih.gov/38583670/","substance_tags":"psilocybin","topic_tags":"Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Review Article,Animal Study,Safety,Immune Function","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 11:08:41","last_checked":"2026-08-09 08:28:08","bibtex":null,"source_record_id":"PMID:38583670","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/38583670/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:38583670","source_url":"https://pubmed.ncbi.nlm.nih.gov/38583670/","doi":"10.1016/j.pharmthera.2024.108641","pmid":"38583670","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2700,"title":"Hallucinogens and dissociative agents naturally growing in the United States.","authors":"Halpern JH","journal":"Pharmacology & therapeutics","publication_date":"2004-05-01","publication_year":2004,"doi":"10.1016/j.pharmthera.2004.03.003","pubmed_id":"15163594","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/15163594/","substance_tags":"psilocybin,psilocin","topic_tags":"Review Article,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:29","bibtex":null,"source_record_id":"PMID:15163594","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/15163594/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:15163594","source_url":"https://pubmed.ncbi.nlm.nih.gov/15163594/","doi":"10.1016/j.pharmthera.2004.03.003","pmid":"15163594","publication_date":"2004-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2347,"title":"Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.","authors":"Johnson MW, Hendricks PS, Barrett FS, Griffiths RR","journal":"Pharmacology & therapeutics","publication_date":"2019-05-01","publication_year":2019,"doi":"10.1016/j.pharmthera.2018.11.010","pubmed_id":"30521880","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/30521880/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Mystical Experience,Review Article,Healthy Volunteers","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:30521880","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/30521880/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:30521880","source_url":"https://pubmed.ncbi.nlm.nih.gov/30521880/","doi":"10.1016/j.pharmthera.2018.11.010","pmid":"30521880","publication_date":"2019-05-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1653,"title":"Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.","authors":"Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR","journal":"Pharmacology & therapeutics","publication_date":"2022-11-01","publication_year":2022,"doi":"10.1016/j.pharmthera.2022.108195","pubmed_id":"35489438","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35489438/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:18","bibtex":null,"source_record_id":"PMID:35489438","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35489438/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35489438","source_url":"https://pubmed.ncbi.nlm.nih.gov/35489438/","doi":"10.1016/j.pharmthera.2022.108195","pmid":"35489438","publication_date":"2022-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1121,"title":"Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases","authors":"Haniff Z, Bocharova M, Mantingh T, Rucker J, Velayudhan L, Taylor D, Young A, Aarsland D, Vernon A, Thuret S.","journal":"Pharmacology & therapeutics","publication_date":"2024-06-01","publication_year":2024,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://europepmc.org/article/PMC/PMC11847495","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:15:17","bibtex":null,"source_record_id":"https://europepmc.org/article/PMC/PMC11847495","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"https://europepmc.org/article/PMC/PMC11847495","source_url":"https://europepmc.org/article/PMC/PMC11847495","doi":"","pmid":"","publication_date":"2024-06-01","importer_version":"2.1.3","text_redistributed":false}}],"total":5,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Pharmacology & therapeutics","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}